FFA
IMVT icon

Farther Finance Advisors’s Immunovant IMVT Stock Holding History

Farther Finance Advisors’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$83.6K Buy
2,475
+3
+0.1% +$118 ﹤0.01% 3010
2026
Q2 		$95.2K Sell
2,472
-14
-0.6% -$427 ﹤0.01% 2735
2026
Q1 		$62.4K Buy
2,486
+9
+0.4% +$233 ﹤0.01% 2842
2025
Q4 		$63K Sell
2,477
-25
-1% -$557 ﹤0.01% 2663
2025
Q3 		$40.3K Sell
2,502
-355
-12% -$5.75K ﹤0.01% 2574
2025
Q2 		$45.7K Buy
2,857
+2,855
+142,750% +$43.2K ﹤0.01% 2178
2025
Q1 		$30 Sell
2
-6
-75% -$126 ﹤0.01% 4167
2024
Q4 		$198 Hold
8
– – ﹤0.01% 3662
2024
Q3 		$228 Buy
8
+6
+300% +$177 ﹤0.01% 3626
2024
Q2 		$55 Hold
2
– – ﹤0.01% 3681
2024
Q1 		$63 Sell
2
-2
-50% -$73 ﹤0.01% 3446
2023
Q4 		$169 Buy
+4
New +$147 ﹤0.01% 3247

Other funds holding IMVT

TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return

Farther Finance Advisors's IMVT Position: Q3 2026 in Review

Farther Finance Advisors increased its Immunovant (IMVT) stake by 0.12% in Q3 2026, buying an estimated $118 and bringing the position to 2,475 shares worth $83.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3010.

Farther Finance Advisors first reported a position in IMVT in Q4 2023 and has held it in 12 quarters since. The position peaked at $95.2K in Q2 2026. 5 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.

  • Farther Finance Advisors held 2,475 shares of Immunovant worth $83.6K as of Q3 2026.
  • Farther Finance Advisors bought 3 Immunovant shares in Q3 2026, an estimated $118.
  • Immunovant made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3010 holding.
  • Farther Finance Advisors first reported a position in Immunovant in Q4 2023 and has held it in 12 quarters since.
  • Farther Finance Advisors's Immunovant position peaked at $95.2K in Q2 2026.
  • 5 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.